Expression and function of indoleamine 2,3-dioxygenase (IDO) following corneal transplantation. (360G-Wellcome-078732_Z_05_Z)
This research is aimed at understanding the role of indoleamine 2,3-dioxygenas to what extent IDO expression has a role in the rejection of corneal allograft the factors that control IDO expression in corneal allograft rejection· whether over-expression of IDO in corneal allografts can prevent rejection· if over-expression of IDO in dendritic cells (DCs) will induce regulatory T-c if administration of IDO expressing DC can prevent graft rejection, and to com
Where is this data from?
This data was originally published by The Wellcome Trust. If you see something about your organisation or the funding it has received on this page that doesn't look right you can submit a grantee amendment request. You can hover over codes from standard codelists to see the user-friendly name provided by 360Giving.
Grant Details
| Amount Awarded | 201302 |
| Applicant Surname | George |
| Approval Committee | Immunology and Infectious Disease Funding Committee |
| Award Date | 2006-02-09T00:00:00+00:00 |
| Financial Year | 2005/06 |
| Grant Programme: Title | Project Grant |
| Internal ID | 078732/Z/05/Z |
| Lead Applicant | Dr Andrew George |
| Other Applicant(s) | Dr Daniel Larkin, Prof Myra McClure |
| Partnership Value | 201302 |
| Planned Dates: End Date | 2009-10-17T00:00:00+00:00 |
| Planned Dates: Start Date | 2006-09-18T00:00:00+00:00 |
| Recipient Org: Country | United Kingdom |
| Region | Greater London |